This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Why Molson Coors Brewing (TAP) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JPME
Why Is Molson Coors (TAP) Down 6.3% Since Last Earnings Report?
by Zacks Equity Research
Molson Coors (TAP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Molson Coors (TAP) Stays on Growth Track Amid Inflation Woes
by Zacks Equity Research
Molson Coors (TAP) has been on track with the revitalization plan, and innovation and premiumization efforts to gain market share and drive sustainable profits.
Should You Invest in the Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS)?
by Zacks Equity Research
Sector ETF report for RSPS
Boston Beer (SAM) Retains Strong Position on Growth Strategies
by Zacks Equity Research
Boston Beer (SAM) is well-placed on its growth initiatives, including innovation, product portfolio expansion, growth of the beyond beer categories, and cost-saving and efficiency projects.
4 Consumer Staples Stocks You Can Bank on for the Months Ahead
by Abhinab Dasgupta
e.l.f. Beauty (ELF), Molson Coors (TAP), J&J Snack (JJSF) and Boston Beer (SAM) are four stocks that you can look into as rate hikes come to a close.
Molson Coors (TAP) Buys Blue Run to Focus on Drinks Beyond Beer
by Zacks Equity Research
Molson Coors' (TAP) latest acquisition of whisky brand Blue Run marks its first spirits acquisition. The move is likely to expand its portfolio beyond beer and aid its premiumization strategy.
Hershey (HSY) Thrives on Innovation & Pricing Amid Cost Woes
by Zacks Equity Research
Hershey's (HSY) robust brand portfolio, strategic pricing initiatives and acquisitions collectively underpin its enduring success and prominence within the confectionery industry.
Zacks.com featured highlights Alibaba, Encompass Health, Molson Coors, Ford Motor and Albemarle
by Zacks Equity Research
Alibaba, Encompass Health, Molson Coors, Ford Motor and Albemarle have been highlighted in this Screen of The Week article.
5 Lucrative Value Picks Based on Discounted PEG
by Urmimala Biswas
Here are five stocks that match our screening criteria, BABA, EHC, TAP, F and ALB.
Here's Why Pilgrim's Pride (PPC) is Well-Poised to Thrive
by Zacks Equity Research
Pilgrim's Prides' (PPC) unwavering focus on diversification, growth with Key Customers and operational excellence has been key to its success amid challenging market conditions.
AB InBev (BUD) Q2 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
AB InBev's (BUD) Q2 results reflect gains from pricing actions, ongoing premiumization and other revenue-management initiatives amid higher costs.
Diageo (DEO) FY23 Results Gain From Productivity Efforts
by Zacks Equity Research
Diageo's (DEO) fiscal 2023 results reflect gains from a robust portfolio of brands, a diversified presence, cost productivity savings and premiumization.
Molson Coors (TAP) Q2 Earnings Beat Estimates, Sales Lag
by Zacks Equity Research
Molson Coors' (TAP) Q2 results reflect gains from strength in its core brands, solid pricing and a favorable sales mix, offset by consumer inflationary pressures and a softer beer industry.
Compared to Estimates, Molson Coors (TAP) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Molson Coors (TAP) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Molson Coors Brewing (TAP) Beats Q2 Earnings Estimates
by Zacks Equity Research
Molson Coors (TAP) delivered earnings and revenue surprises of 9.20% and 1.27%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
3 Consumer Centric Stocks to Buy as Earnings Approach
by Shaun Pruitt
These consumer-centric companies are expected to have posted strong quarterly growth and now may be a good time to buy their stocks for a strengthening outlook.
Factors Likely to Influence AB InBev's (BUD) Q2 Earnings
by Zacks Equity Research
AB InBev (BUD) Q2 results are expected to reflect the benefits of its unique commercial strategy, a strong brand portfolio, and investments in brands and operation excellence.
Here's What Awaits Clorox (CLX) When It Reports Q4 Earnings
by Zacks Equity Research
Clorox's (CLX) Q4 results are expected to reflect gains from solid demand trends, pricing actions, digital investments, cost-saving efforts and the IGNITE strategy.
5 Large-Cap Stocks to Buy Ahead of Q2 Earnings Tomorrow
by Nalak Das
We have narrowed our search to five large-cap stocks that are set to declare second-quarter earnings results on Aug 1. These are: PEG, PAYC, MPLX, TAP, ECL.
FEMSA (FMX) Q2 Earnings Top Estimates on Solid Revenue Growth
by Zacks Equity Research
FEMSA's (FMX) Q2 results reflect gains from strong top-line growth across its business units, gross margin expansion and the inclusion of Proximity Europe.
Factors Likely to Influence Diageo's (DEO) FY23 Earnings
by Zacks Equity Research
Diageo's (DEO) fiscal 2023 results are expected to reflect gains from its effective marketing, strong commercial execution and favorable industry trends of premiumization.
Is a Beat in Store for Molson Coors (TAP) in Q2 Earnings?
by Zacks Equity Research
Despite inflation, Molson Coors' (TAP) second-quarter results are expected to reflect strength in core brands, a revitalization plan and the premiumization of its global portfolio.
Altria Group (MO) Queues for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Altria Group's (MO) second-quarter results are likely to reflect gains from pricing and strength in Oral Tobacco Products, though soft cigarette volumes have been a concern.